You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Trading
Institutions
Fees
Promotions
FAQ
Education
Download
About us
Hong Kong
uSMART
EN
Login/Register
Market News

Market News

HomeMarket NewsDetails

花旗：阿里健康(0241.HK)年度业绩胜预期 维持首要买入看法

格隆汇 05-28 12:59
花旗发表报告表示，阿里健康(0241.HK)公布截至今年3月止财年收入96亿人民币(按年升88%)，优于市场同业原预期6%，期内亏损收窄至660万人民币(2019年亏损8,190万人民币)，亦优于市场原预期亏损8,330万元人民币，期内毛利率由去年26.1%降至期内23.3%。

该行指，将参与阿里健康的分析员会议，维持对其首要买入看法，予“买入”评级及目标价20港元，料公司可受惠内地开放线上药物销售、料在国策支持下公司具强劲的变现能力，而公司与阿里巴巴(9988.HK)在电商货币化及医疗线上到线下具协同效应。

Relevant Recommendation
Business Collaboration
Account Opening

Services

FeesFAQExclusive Trading Tools

About Us

OverviewContact UsMedia Center

Agreement Statement

DisclaimerPrivacy Statement
Contact Us
Customer Service Hotline︰+852 3018 4526
Email︰cs@usmarthk.com
Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong
WhatsApp︰+852 5989 2641
Join the Community：
uSMART-Facebook-Page
uSmart Securities Limited
is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Copyright © 2022 uSMART . All Rights Reserved.